In most cases (85 percent), the stroke is caused by the occlusion of a blood vessel in the brain. This results in the affected area of the brain becoming undersupplied with blood and oxygen, causing nerve tissue to die off beyond retrieval. Despite intensive research activities, only inadequate treatment options are currently available. The medical engineering company MD-5 GmbH, founded with the support of Fraunhofer IZI, has set itself the goal of improving this situation using an innovative treatment method.
The therapy concept developed by MD-5 GmbH is based on a procedure which can specifically influence the blood flow in the brain using magnetic fields. So-called intelligent transcranial magnetic stimulation (iTMS) allows blood flow to be increased in defined regions of the brain, thus limiting damage caused by a stroke. “Several investigations and optimizations are still required before the technology can be introduced into clinical routine as a medical device. Together with the Fraunhofer IZI and Leipzig University Hospital, we look forward to continuing with the development of a prototype which is suitable for practice and preparing its market launch,” commented Dr. Mark K. Borsody, Founder and Chief Medical Officer, describing the cooperation work of the joint project.
“The Fraunhofer IZI is contributing its comprehensive expertise in the areas of stroke research and preclinical development. Expressive model systems are to verify both the safety and efficacy of the procedure. The procedure can then be optimized accordingly by our colleagues at MD-5, based on these investigations,” commented Dr. Antje Dreyer, Head of the Clinic-oriented Therapy Assessment Unit at Fraunhofer IZI, describing the Fraunhofer Institute's role in the project.
With the addition of MD-5 GmbH, founded in Leipzig in October 2012 as a subsidiary of the US company Lake Bioscience LLC, Fraunhofer IZI has managed to bring on board another international partner and increase investment in the biotechnology location of Saxony.
“We are very glad that we succeded in convincing our colleagues from Lake Biosciences to establish their european subsidiary in Leipzig / Saxony” adds Dr. Thomas Tradler, Head of Business Development at the Fraunhofer IZI.
The project, valued at a total of 1.4 million euros, is being funded through the Sächsische Aufbaubank (Saxon Development Bank) with a total of 1.1 million euros coming from the European Regional Development Fund (ERDF) and also from the Free State of Saxony.
The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops specific problem solutions at the interfaces of medicine, life sciences and engineering. The Institute practices contract research for biotechnological, pharmaceutical and medical-technological companies, hospitals, diagnostic laboratories and research facilities. Within the Business Units of Agents, Cell Therapy, Diagnostic and Biobanking, the Institute develops, optimizes and validates methods, materials and products. The Institute's core competencies are located in the field of Regenerative Medicine, in particular in the indication areas of oncology, ischemia and autoimmune, inflammatory and infectious diseases. The Institute is clinically oriented and conducts quality checks and the GMP-compliant manufacture of investigational medicinal products. Moreover, the Institute provides support in obtaining manufacturing authorizations and approvals.
PET identifies which prostate cancer patients can benefit from salvage radiation treatment
05.12.2017 | Society of Nuclear Medicine and Molecular Imaging
Designing a golden nanopill
01.12.2017 | University of Texas at Austin, Texas Advanced Computing Center
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong
Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...
An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications
Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...
Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.
The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...
08.12.2017 | Event News
07.12.2017 | Event News
05.12.2017 | Event News
11.12.2017 | Physics and Astronomy
11.12.2017 | Materials Sciences
11.12.2017 | Earth Sciences